{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260803318492/en/Lantern-Pharma-Nasdaq-LTRN-Establishes-Open-Medicine-AI-as-a-Separate-Company-to-Commercialize-and-Expand-Its-Multi-Agent-AI-Co-Scientist-Platform-for-the-Transformation-of-Medicine", "message": "News view counter 863053 successfully enlarged"}